Edition:
United States

Retrophin Inc (RTRX.O)

RTRX.O on Consolidated Issue listed on NASDAQ Global Market

20.05USD
18 Apr 2019
Change (% chg)

$-0.14 (-0.69%)
Prev Close
$20.19
Open
$20.17
Day's High
$20.33
Day's Low
$19.57
Volume
330,591
Avg. Vol
349,479
52-wk High
$33.00
52-wk Low
$19.57

About

Retrophin, Inc. is a biopharmaceutical company. The Company is focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases. The Company sells three products, including Chenodal (chenodeoxycholic acid), Cholbam (cholic acid) and Thiola (tiopronin). Its... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $948.89
Shares Outstanding(Mil.): 38.39
Dividend: --
Yield (%): --

Financials

  RTRX.O Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.86 -- --
ROI: -15.89 8.91 13.83
ROE: -22.95 10.06 15.25

Earnings vs. Estimates